Literature DB >> 9568444

Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.

P Båvenholm1, U de Faire, C Landou, S Efendic, J Nilsson, B Wiman, A Hamsten.   

Abstract

AIMS: To assess determinants of coronary artery disease progression in men with previous myocardial infarction. METHODS AND
RESULTS: A total of 102 unselected non-diabetic Swedish men (age 40.4 +/- 3.6, range 23-44 years) entered the study 3-6 months after a first myocardial infarction. The programme included metabolic and haemostatic investigations and routine coronary angiography at baseline, followed by re-angiography 5 years later. Of the original cohort, 76 patients underwent a second angiogram. Separate semiquantitative scoring systems were used for diffuse coronary atherosclerosis and distinct stenoses in 15 proximal coronary segments. Smoking, global severity of coronary atherosclerosis and presence of multi-vessel disease at baseline (P < 0.001) characterized patients with severe progression of both diffuse and focal lesions. Higher plasma levels of low density lipoprotein cholesterol (P < 0.01) and low density lipoprotein triglycerides (P < 0.05), a lower plasma high density lipoprotein2 cholesterol level (P < 0.05) and higher plasma plasminogen activator inhibitor-1 activity (P < 0.05), together with a high baseline stenosis score (P < 0.001) characterized patients with severe progression of coronary atherosclerosis. On the other hand, more pronounced fasting and post-prandial glycaemia (P < 0.05), together with higher plasma plasminogen activator inhibitor-1 activity (P < 0.01) characterized severe progressors with respect to coronary stenosis. Multivariate analysis identified the presence of multi-vessel disease as an independent predictor of progression of both coronary atherosclerosis (P = 0.008) and stenoses (P = 0.007), whereas a high low density lipoprotein triglyceride level (P < 0.01) was independently related to progression of coronary atherosclerosis and a high fasting glucose level (P = 0.02) to progression of coronary stenoses.
CONCLUSION: Disturbances in carbohydrate and lipoprotein metabolism and impaired fibrinolytic function are associated with progression of coronary artery disease in young male post-infarction patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568444     DOI: 10.1053/euhj.1997.0752

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

Review 1.  Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.

Authors:  Victoria A Ploplis
Journal:  Curr Drug Targets       Date:  2011-11       Impact factor: 3.465

Review 2.  Fibrinolytic function and coronary risk.

Authors:  I Juhan-Vague; P Morange; M Christine Alessi
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

3.  After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.

Authors:  Okcan Basat; Sema Ucak; Selcuk Seber; Erkan Oztekin; Yuksel Altuntas
Journal:  Clin Res Cardiol       Date:  2006-02-06       Impact factor: 5.460

Review 4.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

5.  A closer look at the role of urotensin II in the metabolic syndrome.

Authors:  Pierre-Olivier Barrette; Adel Giaid Schwertani
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-28       Impact factor: 5.555

6.  Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.

Authors:  M Hoshino; Y Haraguchi; H Hirasawa; M Sakai; H Saegusa; K Hayashi; N Horita; H Ohsawa
Journal:  Crit Care       Date:  2001-02-26       Impact factor: 9.097

7.  Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease.

Authors:  Afsaneh Forood; Reza Malekpour-Afshar; Amin Mahdavi
Journal:  Addict Health       Date:  2014 Summer-Autumn

8.  Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.

Authors:  Sakhavat Abolhasani; Shahnam Valizadeh Shahbazloo; Hossein Mozafar Saadati; Neda Mahmoodi; Nafiseh Khanbabaei
Journal:  Arq Bras Cardiol       Date:  2019-08-29       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.